ISSAR Pharma announces out-licensing of its peptide-based NCEs
ISSAR has several patents for peptide molecules lined up in their development pipeline targeting therapeutic areas such as…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.